glp 1 food aversion When Becomes Unappealing on GLP-1s: A Guide to Managing Food Aversions First they took a GLP-1.

Furthermore, lifestyle choices and habits are integral to sustainable weight loss

Lee and Jun 2016)

semaglutide for obesity showed tirzepatide 10 mg or 15 mg produced significantly greater reductions in body weight and waist circumference over 72 weeks compared to semaglutide 1.7 mg or 2.4 mg, with both drugs having mostly mild-to-moderate gastrointestinal side effects during dose escalation

PMID 18640588

His cholesterol dropped to 220 mg/dLstill somewhat elevated but his lowest number in three years

They have demonstrated a consistent reduction in the risk of mortality in patients with T2D and established heart disease, and in patients with HF with reduced ejection fraction (HFrEF)